U.S. Pharmaceutical Lipid-based Excipients Market Size & Outlook
U.S. pharmaceutical lipid-based excipients market, 2018-2030 (US$M)
Related Markets
U.S. pharmaceutical lipid-based excipients market highlights
- The U.S. pharmaceutical lipid-based excipients market generated a revenue of USD 423.4 million in 2024 and is expected to reach USD 548.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.4% from 2025 to 2030.
- In terms of segment, oils was the largest revenue generating excipient type in 2024.
- Lecithin and Phospholipids is the most lucrative excipient type segment registering the fastest growth during the forecast period.
Pharmaceutical lipid-based excipients market data book summary
| Market revenue in 2024 | USD 423.4 million |
| Market revenue in 2030 | USD 548.4 million |
| Growth rate | 4.4% (CAGR from 2025 to 2030) |
| Largest segment | Oils |
| Fastest growing segment | Lecithin and Phospholipids |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oils, Hydrogenated Vegetable Oils, GMCC (Glyceryl Monostearate), Hard Fats, Medium Chain Triglycerides (MCTs), Lecithin and Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types |
Other key industry trends
- In terms of revenue, U.S. accounted for 23.2% of the global pharmaceutical lipid-based excipients market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. pharmaceutical lipid-based excipients market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 21.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Lipid-Based Excipients Market Scope
Pharmaceutical Lipid-Based Excipients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. pharmaceutical lipid-based excipients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical lipid-based excipients market will help companies and investors design strategic landscapes.
Oils was the largest segment with a revenue share of 42.16% in 2024. Horizon Databook has segmented the U.S. pharmaceutical lipid-based excipients market based on oils, hydrogenated vegetable oils, gmcc (glyceryl monostearate), hard fats, medium chain triglycerides (mcts), lecithin and phospholipids, sodium oleate, capri caprylic mono diglyceride, other excipient types covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. pharmaceutical lipid-based excipients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. pharmaceutical lipid-based excipients market databook
-
Our clientele includes a mix of pharmaceutical lipid-based excipients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pharmaceutical lipid-based excipients market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pharmaceutical lipid-based excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. pharmaceutical lipid-based excipients market size, by excipient type, 2018-2030 (US$M)
U.S. Pharmaceutical Lipid-Based Excipients Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
